Poor aqueous solubility has always been remained a challenge for delivery of drugs and show dissolution rate limited absorption. This problem seeks more attention in current time where number of poorly soluble candidates have increased up to 70 percent or more. Although extensive research efforts led to many successful marketed products using some commonly used solubility enhancement techniques such as micronization, salt formation, solid dispersion and complexation etc., each of the technique is associated with its own limitations. Nanonization approach involves transfer of poorly soluble materials into the nanodimension that changes their physical properties, and was utilized in pharmaceutical development of an innovative technology; known as drug nanocrystals. Among various nanotechnological approaches, nanocrystals have been emerged as one of the potential technology to overcome issues related to poor water solubility of drugs and its in vivo consequences. This article overviews the feasibility of nanocrystals for administration of poorly soluble drugs by oral, parenteral, dermal, mucosal, pulmonary, ocular and targeted delivery.